BGNE
$122.99
Beigene Ltd ADR
($12.18)
(9.01%)
BGNE
Earnings Whisper ®
N/A
2nd Quarter June 2022
Consensus:  ($4.38)
Revenue:  $332.26 Mil
Thursday
Aug 4
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when BGNE reports earnings?
Beat
Meet
Miss

Where is BGNE's stock price going from here?
Up
Flat
Down
Stock chart of BGNE
Analysts
Summary of analysts' recommendations for BGNE
Score
Grade
Pivots
Resistance
$144.99
$141.83
$138.50

$135.35

Support
$132.02
$128.86
$125.53
Tweet
Growth
Description
BeiGene, Ltd. is a biotechnology company which focused on immuno-oncological therapeutics. The company's clinical-stage drug candidates include BGB-3111, BGB-283, BGB-290, and BGB-A317. BeiGene, Ltd. is based in Camana Bay, Cayman Islands.
›